164 results about "Weight management" patented technology

The invention discloses noodles with a blood sugar control function, which comprise the following components in parts by weight: 150-170 parts of triticale flour, 10-30 parts of cyperus esculentus powder, table salt and water, and 4-10 parts of dietary fibers, 0.5 to 1 part of anthocyanin; 0.03 to 0.12 part of mineral substances and 0.2 to 0.5 part of vitamin B. The traditional Chinese medicine composition has the effects of improving digestion and metabolism, delaying senescence, strengthening body functions, assisting in controlling blood sugar, enhancing satiety and assisting weight management.

The invention relates to the technical field of AI intelligent management, and discloses an AI-based body weight intelligent management method and system, and the method comprises the steps: carrying out the bioelectrical impedance signal collection of M measurement nodes of a target user through an Internet of Things front-end device, and obtaining a multi-node impedance signal set; biological impedance space-time atlas analysis is executed through the cloud processing platform, and human body composition feature data are obtained; aI analysis is carried out through a Deepseek multi-expert model of the cloud processing platform to obtain a weight management analysis result of each professional field; weight fusion and causal inference are carried out through the cloud processing platform in combination with weight management analysis results of all professional fields and doctor review results, and a personalized weight reduction management strategy is generated; the personalized weight reduction management strategy is received through the mobile terminal, dynamic adjustment is carried out in combination with daily execution feedback data of the target user, an intelligent weight management guidance scheme is generated, and the method improves the management effect of AI weight intelligent management and user experience.

The invention relates to the technical field of weight management, in particular to diglyceride oil powder for weight management and a preparation method of the diglyceride oil powder. The invention discloses diglyceride oil powder for weight management. The diglyceride oil powder comprises the following substances in parts by weight: 18-30 parts of flaxseed diglyceride; 10 to 20 parts of a konjak extract; 3 to 8 parts of L-carnitine; 3-8 parts of a white kidney bean extract; 2-5 parts of a green coffee extract; the flaxseed diglyceride is flaxseed diglyceride in which the sn-1, 3 structure proportion is greater than or equal to 85%. The multi-target body weight regulation network is constructed by taking flaxseed diglyceride as a core and combining the konjak extract, the L-carnitine, the white kidney bean extract and the green coffee extract. And a synergistic effect of'fat-carbon water double blocking + energy consumption 'is formed. The composition breaks through the action limitation of a single component by regulating and controlling full links of intake, absorption and metabolism.

The invention discloses a composition for regulating body weight through satiety-sugar control double channels. The composition is prepared from the following components in parts by weight: 5-25 parts of cinnamon extract, 1-20 parts of ganoderma lucidum EGCG composite powder, 10-40 parts of L-arabinose, 5-40 parts of composite fruit and vegetable fiber powder, 5-25 parts of fructus cannabis protein peptide, 1-20 parts of apple polyphenol, 1-20 parts of white kidney bean dietary fiber powder and 1-20 parts of agaricus bisporus powder. The composition is characterized in that digestion and absorption of carbohydrate are inhibited, the swelling ratio larger than or equal to 35 times is achieved through a composite fiber system, gastric emptying is remarkably prolonged, satiety hormones such as GLP-1 are adjusted, and the composition can be used as a non-alternative weight management product and is good in safety.

The present application relates to heterobicyclic compounds having glucagon-like peptide receptor (GLP-1R) agonist activity, processes for their preparation, pharmaceutical compositions comprising them and their use as GLP-1R agonists or for the treatment or prophylaxis of GLP-1R associated diseases or disorders. In particular, the compounds of the present application are useful for body weight management, for lowering blood sugar and / or for the treatment or prevention of diabetes, diabetic complications, obesity, overweight, dyslipidemia, fatty liver diseases (e.g., non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)), metabolic diseases, cardiovascular diseases, nervous system disorders, mental disorders, kidney diseases, etc. , gastrointestinal diseases, autoimmune diseases, inflammatory diseases, lung diseases, hypothalamic-pituitary-gonad axis related diseases or disorders, cancers and the like.

The invention discloses a preparation method and application of a composite probiotic preparation which has a fat reducing function and comprises Lactobacillus rhamnosum D8A, and belongs to the technical field of probiotics. The probiotics can inhibit the growth of obesity-related pathogenic bacteria lactobacillus cloacae, and the content of chlorogenic acid and polysaccharide is remarkably increased through specific fermentation of honeysuckle. The extracted polysaccharide shows fat-reducing activity through verification of a 3T3-L1 cell model, and animal experiments show that the effect of the probiotic preparation prepared based on the polysaccharide embedding technology developed on the basis is obviously better than that of other preparations. The invention provides an innovative solution for developing a fat-reducing probiotic preparation, and has important application value in the fields of functional food and weight management.

The present application relates to use of Ligilactobacillus salivarius in preparing a drug for preventing and / or treating diseases associated with overweight and / or obesity . The strain can inhibit the weight growth of a high-fat diet-induced obesity model mouse, reduce the blood lipid level of the high-fat diet-induced obesity model mouse, improve the liver injury index of the high-fat diet-induced obesity model mouse, reduce the area of white adipose cells of the high-fat diet-induced obesity model mouse, improve the colon GLP-1 level of the high-fat diet-induced obesity model mouse, improve the intestinal flora imbalance of the high-fat diet-induced obesity model mouse, and improve the liver glycolipid metabolism of the high-fat diet-induced obesity model mouse; and reduce the waist circumference, hip circumference, body fat mass, BMI, and weight of overweight and overweight and / or obesity volunteers, and maintain the muscle content, promoting overweight and overweight and / or obesity people to carry out safe, effective, and sustainable weight management.

The present invention relates to the technical field of food and drugs, and in particular to a hydrogel material composition, and a weight management composition, a preparation method therefor and a use thereof. The hydrogel material composition comprises konjac powder, galactomannan, and resistant dextrin. The weight management composition comprises the following components in parts by mass: 40-60 parts of a hydrogel material composition, 10-40 parts of a disintegrating agent, 0-15 parts of inorganic salt, and 10-35 parts of a filler. In the present invention, the composition prepared from specific components and by specific proportions can have good preparation performance, disintegration performance, and gelling performance; the product quality stability is high; the composition is suitable for large-scale application development; and the composition can occupy the space in the stomach after being eaten, so that satiety is promoted, and the appetite is reduced, thereby achieving the purposes of realizing weight management, blood sugar control and the like.

The present invention relates to semaglutide for use in weight management.

The invention pertains to an inhalable dry powder formulation comprising a therapeutically effective amount of Glucagon-like peptide-1 (GLP-1) receptor agonist. Further, use of the inhalable dry powder formulation treatment of chronic weight management for people who are overweight or obese, with or without a weight-related comorbid condition. Further, a process for forming particles comprising a Glucagon- like peptide-1 (GLP-1) receptor agonist suitable for airborne inhalation.

1. Name of the product of this design: Dining Tray (Weight Management). 2. Purpose of this design product: used for holding food. 3. The key design points of this product are the combination of shape, pattern and color. 4. The picture or photo that best illustrates the design points: three-dimensional picture. 5. The design for which protection is sought includes color.

The invention specifically relates to a smoking cessation person weight management auxiliary method and system, and the method comprises the steps: obtaining a current multi-source weight data set of a user in response to a user data feedback signal of a smoking cessation person, the current multi-source weight data set at least comprises genotype data features of the user, current weight data features and various types of life behavior data features; the current multi-source weight data set of the user is substituted into the intelligent weight management model, a weight management scheme matched with the user is selectively updated or generated, and the weight management scheme at least comprises a diet suggestion parameter set, an exercise suggestion parameter set and a current target combination parameter set; and obtaining a feedback instruction of the user for the body weight management scheme matched with the user, and selectively adjusting the intelligent body weight management model based on the feedback instruction. When the change of any data of the smoking cessation person is monitored, the body weight management scheme is automatically adjusted, and it is ensured that the user is matched with the body weight management scheme.

This invention discloses a weight management system, method, device, and storage medium for overweight and obese individuals based on standardized operating procedures, belonging to the field of health management technology. It includes an information collection and standardized input module; a health risk analysis and assessment module; a personalized intervention plan configuration module; a dynamic intervention execution and tracking management module; and an effect evaluation and optimization feedback module. The system of this invention achieves standardized collection of multi-dimensional basic data of users, health risk assessment and classification, standardized health risk assessment and classification, and effect evaluation and optimization feedback by constructing a collaborative operating system of the information collection and standardized input module, the health risk analysis and assessment module, the personalized intervention plan configuration module, the dynamic intervention execution and tracking management module, and the effect evaluation and optimization feedback module. Simultaneously, it identifies abnormal behaviors and generates early warning information through early warning rules, and uses the effect evaluation and optimization feedback module to comprehensively evaluate and dynamically optimize the intervention plan execution process.

This invention discloses a compound peptide nutrient with fat-reducing effects, belonging to the field of health food technology. Specifically, it relates to a VQPIPY peptide or a product containing VQPIPY peptide in the preparation of lipid-lowering drugs or health products, or in the preparation of drugs for treating and / or alleviating alcoholic liver damage. This invention also provides a meal replacement powder containing VQPIPY peptide, shown as a compound of whey powder, milk powder, oats, spinach powder, allulose, and camel milk peptide in a specific ratio. Through the synergistic effect of its components, this product achieves multiple effects such as providing satiety, inhibiting blood sugar, and lowering blood lipids. It is characterized by balanced nutrition, safety, effectiveness, and good taste, and can be used for weight management and daily health maintenance.

The present application relates to a weight management method and system, and to the technical field of weight management, the method comprising: obtaining heart rate information sent by a first smart terminal and mentality information corresponding to the heart rate information; obtaining diet information of the day recorded by diet software in a second smart terminal; the diet information includes food types and food weights; the second smart terminal is a smart phone; obtaining exercise information sent by the first smart terminal or a bound exercise APP; obtaining excretion information recorded in the second smart terminal; the excretion information includes excretion type and excretion time; the excretion information is obtained by being filled in by the user and then saved; obtaining sleep information recorded in the first smart terminal; obtaining a weight management score and a weight management suggestion plan based on the mentality information, diet information, exercise information, excretion information and sleep information; and sending the weight management score and the weight management suggestion plan to the second smart terminal.

This invention discloses the application of *Lactobacillus plantarum* TWK10 in the preparation of health foods or drugs that enhance exercise motivation. *Lactobacillus plantarum* TWK10, with its Latin name *Lactobacillus plantarum*, was deposited on June 27, 2022, at the China General Microbiological Culture Collection Center (CGMCC), located at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, with accession number CGMCC NO. 25190. This invention fills a technological gap in the field of probiotics for sports psychology intervention, providing a new strategy for "physiological-psychological" dual-effect intervention in sports nutrition, and can be further applied to weight management.

The invention provides a coffee and soybean milk composition for body weight management and a preparation method thereof. The coffee and soybean milk composition comprises the following components in parts by mass: 10-20 parts of a coffee component, 20-60 parts of a soybean protein component, 5-10 parts of a mitochondrial activator and 5-15 parts of dietary fibers. According to the coffee and soybean milk composition provided by the invention, the coffee component, the soybean protein component, the mitochondrial activator and the dietary fiber are scientifically and specifically proportioned, so that key functional components, namely caffeine and chlorogenic acid in coffee, generate a synergistic biological effect with the soybean protein; and a coordinated regulation system of a targeted lipid metabolism full chain is systematically constructed. According to the preparation method, the coffee-dietary fiber microcapsule powder is obtained through a microencapsulation process, the structure can effectively protect heat-sensitive components such as chlorogenic acid and part of aroma substances in coffee from being damaged in the processing and storage process, and the synergistic effect performance of beneficial components in the coffee and soybean milk composition in the human body is guaranteed.

A method for promoting weight management in a mammal is provided, comprising administering to the mammal a weight loss agent and a mitochondria enhancing agent. Compositions for weight management are also provided.

The present disclosure relates to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity and / or chronic weight management, dyslipidemia and / or NASH. The disclosure relates to compounds that agonize the amylin receptor and can lower food intake, body weight, glucose and / or triglycerides, so can be used to treat diabetes, obesity, and / or dyslipidemia. The present disclosure also includes pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions.

The present invention provides a method of increasing glycemic control in a patient in need thereof by administering tizatide, or a pharmaceutically acceptable salt thereof. The present invention provides a method of improving body weight management in a patient in need thereof by administering tizatide, or a pharmaceutically acceptable salt thereof. Also provided is a method of treating a condition selected from the group consisting of atherosclerosis, chronic kidney disease, NAFLD and NASH. Also provided is a method of preventing or causing alleviation of diabetes mellitus, comprising administering tizatide or a pharmaceutically acceptable salt thereof. Also provided is a dosing regimen for increasing glycemic control, improving weight management, and / or treating dyslipidemia.

The invention provides a composition for body weight management as well as a preparation method and application thereof. The composition for body weight management is prepared from the following raw materials: raspberry, sophora flower bud, cinnamon, poria cocos, oat and grapefruit. According to the present invention, according to the traditional Chinese medicine diet therapy concept, the raspberry, the sophora flower bud, the cinnamon, the poria cocos, the oat, the grapefruit and other medicinal and edible components are selected, and the components beneficial to weight management are matched based on the modern scientific research, such that the compatibility principle of monarch, minister, assistant and guide is provided, and the clear targeting effect mechanism is provided; six components in the composition have a synergistic effect, and the obvious effects of weight management, weight losing and fat reducing can be achieved.

The invention provides a sugar-free cereal nutrition energy bar and a preparation method thereof, relates to the technical field of energy bars, and aims to meet the health requirements of specific crowds such as diabetics and dieters. The energy bar consists of dietary fiber grains, crushed walnuts, dried fruits, white kidney beans, astragalus membranaceus, Chinese wolfberry fruits, Chinese yams, poria cocos, whey protein powder, cellulase, amylase and a healthy adhesive. The preparation method comprises the following steps: pre-baking grains, mixing and soaking beans and medicinal materials, performing enzyme treatment, performing enzyme deactivation and drying, and performing shaping and baking. According to the method, rich nutrition is provided by carefully selecting raw materials and proportions, and meanwhile, a sugar-free formula adapts to special diet requirements and contributes to blood sugar control and weight management. The product has long satiety, reduces hunger sensation, and plays a positive role in health management and weight control. Sensory evaluation and nutritional index analysis prove the effectiveness and nutritional value of the invention.

The present invention discloses a guarana extract – EGCG synergistic fat-burning composition, belonging to the technical field of functional foods and weight management. The composition comprises guarana extract, epigallocatechin gallate, and konjac glucomannan. By controlling the component ratio and key parameters, a dynamic gel network formed by konjac glucomannan provides in-situ protection of active ingredients and enables programmed release in the gastrointestinal tract, while constructing a multi-level appetite-suppression system with temporal continuity.The invention overcomes problems in the prior art, including poor stability, low bioavailability, and fragmented appetite regulation, and achieves synergistic effects in fat burning and intake control. It is suitable for preparing oral solid formulations, with high safety, good stability, and suitability for large-scale industrial production and commercialization.

The invention discloses a composition capable of being used for body weight management and a preparation method and application thereof, and belongs to the technical field of foods.The composition is prepared from, by weight, 15-50 parts of compound protein powder solid beverage, 2-15 parts of quinoa flour and 1-8 parts of compound fruit and vegetable powder. The quinoa flour is prepared through high-pressure homogenization, composite enzymolysis, ethanol extraction and supercritical extraction. Experiments prove that the chenopodium quinoa flour prepared by the method has more advantages in the aspect of controlling weight management, and the goals of enhancing satiety and reducing total calorie intake are achieved while nutrition balance is guaranteed through the combined action of the chenopodium quinoa flour, the compound protein powder solid beverage and the compound fruit and vegetable powder.

The invention discloses application of a nutritional composition containing alpha-hydroxyisocaproic acid in weight management and blood fat improvement, and belongs to the fields of biological medicine manufacturing, biological medicine application and functional food development. The nutritional composition comprises alpha-hydroxyisocaproic acid and at least one second functional nutritional component, and the second functional nutritional component is preferably selected from one or more of the following components: 1) one or more of tea polyphenol and capsaicin; 2) one or more of beta-glucan, inulin and resistant dextrin; 3) one or more of medium chain triglyceride and sn-1, 3 diglyceride; under the condition of the same intake cycle and dosage, the nutritional composition can significantly improve the weight management effect and reduce related indexes of blood fat through a multi-way synergistic effect, and is combined with GLP-1 drugs or sequentially applied to weight management so as to reduce the risk of weight rise after drug withdrawal.

A value-based method of treating musculoskeletal pain is described, which includes care for the exacerbating coexisting physical and behavioral health concerns and the social determinants of health; all without bundling in surgery. In general, the techniques described may relate to a specific combination of treatment methodologies, including pain management, physical therapy, physical fitness and nutrition, weight management, behavioral health, substance abuse treatment, smoking cessation, reliable case management, and prompt referral for acute or severe pathological conditions.

The present invention relates to pharmaceutical combinations comprising bupropion and trazodone and methods of using the same for affecting weight loss in subjects who may be obese, overweight or desire to lose undesirable or unwanted weight. The present invention also relates to pharmaceutical combinations comprising bupropion and trazodone and methods of using the same for inducing weight loss, effectuating weight management, improving a sexual disorder, and / or improving low or poor or a lack of a subjective state of well-being, self-esteem, and / or self-confidence in subjects who may be obese, overweight or desire to lose undesirable or unwanted weight or who want to maintain weight. The present invention also relates to pharmaceutical combinations comprising bupropion and trazodone and methods of using the same for weight loss and / or weight maintenance management.

An integrated weight management system comprising a biocompatible intraoral device and personalized software is disclosed. The device, configured for insertion into the user's mouth, creates a separation between the tongue and teeth causing the stomatognathic system, limiting hunger cues associated with food anticipation. Sensors coupled to the device detect its removal and insertion, enabling the system to track adherence to meal plans and weight loss progress. The software utilizes machine learning algorithms to generate personalized meal plans, food intake timing, nutrition education, and exercise routines based on user preferences, dietary restrictions, and weight loss goals. The system analyzes user data to provide progress reports, adjust meal plans, and send alerts to promote accountability and compliance. This comprehensive approach addresses both physiological and psychological aspects of weight management, offering a novel and effective solution for achieving and maintaining a healthy weight.

A polypeptide that is active against each of a GIP, a GLP-1, and a glucagon receptor is provided. The polypeptides have structural features that result in each of the receptors having activity and extended action time. Also provided are methods for treating diseases and / or conditions such as obesity, long term weight management, type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), dyslipidemia, metabolic syndrome, chronic kidney disease (CKD), osteoarthritis (OA), obesity-associated sleep apnea (OSA), and polycystic ovarian syndrome (PCOS).